Bicalutamide Market Report

Global and Regional Bicalutamide Market Details Research Report 2021-2026

  • POSTDATE：Jun 25, 2021
  • PAGES：178
  • REPORT CODE：GMM720174
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Bicalutamide Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Bicalutamide market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Bicalutamide market.

    By Player:

    • Apotex Corporation

    • Fresenius Kabi

    • Shanghai Fudan Fuhua Pharmaceutical

    • ANI Pharmaceuticals

    • Accel Pharma

    • Sorres Pharma

    • AstraZeneca

    • Shanxi Zhendong Pharmaceutical

    • Zhejiang Haizheng Pharmaceutical

    • CORDEN PHARMA GMBH

    • Sivem Pharmaceuticals

    • Actavis Pharma

    • Zeneca GmbH

    • Shanghai Zhaohui Pharmaceutical

    By Type:

    • Tablets

    • Capsule

    By End-User:

    • Single Drug For Prostate Cancer

    • Combined Chemotherapy For Prostate Cancer

    • Combined Radiation Therapy Or Castration For Prostate Cancer

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Bicalutamide Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Bicalutamide Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Bicalutamide Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Bicalutamide Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Bicalutamide Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Bicalutamide Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Apotex Corporation

      • 3.1.1 Apotex Corporation - Company Business Overview

      • 3.1.2 Apotex Corporation - Company Financial Performance

      • 3.1.3 Apotex Corporation - Company Financial Performance of Bicalutamide

      • 3.1.4 Bicalutamide Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Fresenius Kabi

      • 3.2.1 Fresenius Kabi - Company Business Overview

      • 3.2.2 Fresenius Kabi - Company Financial Performance

      • 3.2.3 Fresenius Kabi - Company Financial Performance of Bicalutamide

      • 3.2.4 Bicalutamide Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Shanghai Fudan Fuhua Pharmaceutical

      • 3.3.1 Shanghai Fudan Fuhua Pharmaceutical - Company Business Overview

      • 3.3.2 Shanghai Fudan Fuhua Pharmaceutical - Company Financial Performance

      • 3.3.3 Shanghai Fudan Fuhua Pharmaceutical - Company Financial Performance of Bicalutamide

      • 3.3.4 Bicalutamide Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 ANI Pharmaceuticals

      • 3.4.1 ANI Pharmaceuticals - Company Business Overview

      • 3.4.2 ANI Pharmaceuticals - Company Financial Performance

      • 3.4.3 ANI Pharmaceuticals - Company Financial Performance of Bicalutamide

      • 3.4.4 Bicalutamide Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Accel Pharma

      • 3.5.1 Accel Pharma - Company Business Overview

      • 3.5.2 Accel Pharma - Company Financial Performance

      • 3.5.3 Accel Pharma - Company Financial Performance of Bicalutamide

      • 3.5.4 Bicalutamide Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Sorres Pharma

      • 3.6.1 Sorres Pharma - Company Business Overview

      • 3.6.2 Sorres Pharma - Company Financial Performance

      • 3.6.3 Sorres Pharma - Company Financial Performance of Bicalutamide

      • 3.6.4 Bicalutamide Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 AstraZeneca

      • 3.7.1 AstraZeneca - Company Business Overview

      • 3.7.2 AstraZeneca - Company Financial Performance

      • 3.7.3 AstraZeneca - Company Financial Performance of Bicalutamide

      • 3.7.4 Bicalutamide Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Shanxi Zhendong Pharmaceutical

      • 3.8.1 Shanxi Zhendong Pharmaceutical - Company Business Overview

      • 3.8.2 Shanxi Zhendong Pharmaceutical - Company Financial Performance

      • 3.8.3 Shanxi Zhendong Pharmaceutical - Company Financial Performance of Bicalutamide

      • 3.8.4 Bicalutamide Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Zhejiang Haizheng Pharmaceutical

      • 3.9.1 Zhejiang Haizheng Pharmaceutical - Company Business Overview

      • 3.9.2 Zhejiang Haizheng Pharmaceutical - Company Financial Performance

      • 3.9.3 Zhejiang Haizheng Pharmaceutical - Company Financial Performance of Bicalutamide

      • 3.9.4 Bicalutamide Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 CORDEN PHARMA GMBH

      • 3.10.1 CORDEN PHARMA GMBH - Company Business Overview

      • 3.10.2 CORDEN PHARMA GMBH - Company Financial Performance

      • 3.10.3 CORDEN PHARMA GMBH - Company Financial Performance of Bicalutamide

      • 3.10.4 Bicalutamide Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 Sivem Pharmaceuticals

      • 3.11.1 Sivem Pharmaceuticals - Company Business Overview

      • 3.11.2 Sivem Pharmaceuticals - Company Financial Performance

      • 3.11.3 Sivem Pharmaceuticals - Company Financial Performance of Bicalutamide

      • 3.11.4 Bicalutamide Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Actavis Pharma

      • 3.12.1 Actavis Pharma - Company Business Overview

      • 3.12.2 Actavis Pharma - Company Financial Performance

      • 3.12.3 Actavis Pharma - Company Financial Performance of Bicalutamide

      • 3.12.4 Bicalutamide Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Zeneca GmbH

      • 3.13.1 Zeneca GmbH - Company Business Overview

      • 3.13.2 Zeneca GmbH - Company Financial Performance

      • 3.13.3 Zeneca GmbH - Company Financial Performance of Bicalutamide

      • 3.13.4 Bicalutamide Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Shanghai Zhaohui Pharmaceutical

      • 3.14.1 Shanghai Zhaohui Pharmaceutical - Company Business Overview

      • 3.14.2 Shanghai Zhaohui Pharmaceutical - Company Financial Performance

      • 3.14.3 Shanghai Zhaohui Pharmaceutical - Company Financial Performance of Bicalutamide

      • 3.14.4 Bicalutamide Product Benchmarking

      • 3.14.5 Strategic Initiatives

    4 Global Bicalutamide Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Bicalutamide Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Tablets 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Capsule 2016-2021

    • 4.3 Global Bicalutamide Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Tablets 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Capsule 2016-2021

    • 4.4 Global Bicalutamide Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Bicalutamide Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Bicalutamide Market Price By Type from 2016 to 2026

    5 Global Bicalutamide Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Bicalutamide

    • 5.2 Global Bicalutamide Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Single Drug For Prostate Cancer 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Combined Chemotherapy For Prostate Cancer 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer 2016-2021

    • 5.3 Global Bicalutamide Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Single Drug For Prostate Cancer 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Combined Chemotherapy For Prostate Cancer 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer 2016-2021

    • 5.4 Global Bicalutamide Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Bicalutamide Market Sales and Market Share by Application (Forecast)

    6 Global Bicalutamide Market Segment Analysis (Geography Level)

    • 6.1 Global Bicalutamide Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Bicalutamide Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Bicalutamide Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Bicalutamide Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Bicalutamide Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Bicalutamide Market from 2016 to 2020

    7. North America Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Bicalutamide Market Segment by Countries

      • 7.1.1 North America Bicalutamide Market Revenue Segment by Countries

      • 7.1.2 North America Bicalutamide Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Bicalutamide Market Segment (Product Type Level)

    • 7.3 North America Bicalutamide Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Bicalutamide Market Segment by Countries

      • 8.1.1 Europe Bicalutamide Market Revenue Segment by Countries

      • 8.1.2 Europe Bicalutamide Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Bicalutamide Market Segment (Product Type Level)

    • 8.3 Europe Bicalutamide Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Bicalutamide Market Segment by Countries

      • 9.1.1 Asia Bicalutamide Market Revenue Segment by Countries

      • 9.1.2 Asia Bicalutamide Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Bicalutamide Market Segment (Product Type Level)

    • 9.3 Asia Bicalutamide Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Bicalutamide Market Segment by Countries

      • 10.1.1 South America Bicalutamide Market Revenue Segment by Countries

      • 10.1.2 South America Bicalutamide Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Bicalutamide Market Segment (Product Type Level)

    • 10.3 South America Bicalutamide Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Bicalutamide Market Segment by Countries

      • 11.1.1 Middle East Bicalutamide Market Revenue Segment by Countries

      • 11.1.2 Middle East Bicalutamide Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Bicalutamide Market Segment (Product Type Level)

    • 11.3 Middle East Bicalutamide Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Bicalutamide Market Segment by Countries

      • 12.1.1 Africa Bicalutamide Market Revenue Segment by Countries

      • 12.1.2 Africa Bicalutamide Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Bicalutamide Market Segment (Product Type Level)

    • 12.3 Africa Bicalutamide Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Bicalutamide Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Bicalutamide Market Segment by Countries

      • 13.1.1 Oceania Bicalutamide Market Revenue Segment by Countries

      • 13.1.2 Oceania Bicalutamide Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Bicalutamide Market Segment (Product Type Level)

    • 13.3 Oceania Bicalutamide Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Bicalutamide Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Bicalutamide

      • 14.2.2 Manufacturing Process Analysis of Bicalutamide

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Bicalutamide Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Bicalutamide Industry Market Status, Pre-COVID-19

      • 15.5.3 Bicalutamide Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Bicalutamide Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Bicalutamide Product Picture

    • Table Bicalutamide Product Definition

    • Table Study Scope by Types

    • Figure Global Bicalutamide Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Bicalutamide Market Value by Application (2016 - 2026)

    • Figure Global Bicalutamide Market Size and Growth Rate from 2016 to 2026

    • Table Global Bicalutamide Production Capacity by Manufacturers (2016-2021)

    • Table Global Bicalutamide Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Bicalutamide Revenue by Manufacturers (2016-2021)

    • Table Global Bicalutamide Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Bicalutamide Plant Distribution and Sales Country

    • Table Apotex Corporation - Company Business Overview

    • Figure Apotex Corporation Total Revenue from 2018 to 2020

    • Table Apotex Corporation Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Apotex Corporation Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Apotex Corporation

    • Table Bicalutamide Product Benchmarking

    • Table Fresenius Kabi - Company Business Overview

    • Figure Fresenius Kabi Total Revenue from 2018 to 2020

    • Table Fresenius Kabi Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Fresenius Kabi Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Fresenius Kabi

    • Table Bicalutamide Product Benchmarking

    • Table Shanghai Fudan Fuhua Pharmaceutical - Company Business Overview

    • Figure Shanghai Fudan Fuhua Pharmaceutical Total Revenue from 2018 to 2020

    • Table Shanghai Fudan Fuhua Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Shanghai Fudan Fuhua Pharmaceutical Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Shanghai Fudan Fuhua Pharmaceutical

    • Table Bicalutamide Product Benchmarking

    • Table ANI Pharmaceuticals - Company Business Overview

    • Figure ANI Pharmaceuticals Total Revenue from 2018 to 2020

    • Table ANI Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure ANI Pharmaceuticals Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of ANI Pharmaceuticals

    • Table Bicalutamide Product Benchmarking

    • Table Accel Pharma - Company Business Overview

    • Figure Accel Pharma Total Revenue from 2018 to 2020

    • Table Accel Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Accel Pharma Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Accel Pharma

    • Table Bicalutamide Product Benchmarking

    • Table Sorres Pharma - Company Business Overview

    • Figure Sorres Pharma Total Revenue from 2018 to 2020

    • Table Sorres Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sorres Pharma Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Sorres Pharma

    • Table Bicalutamide Product Benchmarking

    • Table AstraZeneca - Company Business Overview

    • Figure AstraZeneca Total Revenue from 2018 to 2020

    • Table AstraZeneca Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure AstraZeneca Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Bicalutamide Product Benchmarking

    • Table Shanxi Zhendong Pharmaceutical - Company Business Overview

    • Figure Shanxi Zhendong Pharmaceutical Total Revenue from 2018 to 2020

    • Table Shanxi Zhendong Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Shanxi Zhendong Pharmaceutical Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Shanxi Zhendong Pharmaceutical

    • Table Bicalutamide Product Benchmarking

    • Table Zhejiang Haizheng Pharmaceutical - Company Business Overview

    • Figure Zhejiang Haizheng Pharmaceutical Total Revenue from 2018 to 2020

    • Table Zhejiang Haizheng Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Zhejiang Haizheng Pharmaceutical Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Zhejiang Haizheng Pharmaceutical

    • Table Bicalutamide Product Benchmarking

    • Table CORDEN PHARMA GMBH - Company Business Overview

    • Figure CORDEN PHARMA GMBH Total Revenue from 2018 to 2020

    • Table CORDEN PHARMA GMBH Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure CORDEN PHARMA GMBH Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of CORDEN PHARMA GMBH

    • Table Bicalutamide Product Benchmarking

    • Table Sivem Pharmaceuticals - Company Business Overview

    • Figure Sivem Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Sivem Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sivem Pharmaceuticals Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Sivem Pharmaceuticals

    • Table Bicalutamide Product Benchmarking

    • Table Actavis Pharma - Company Business Overview

    • Figure Actavis Pharma Total Revenue from 2018 to 2020

    • Table Actavis Pharma Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Actavis Pharma Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Actavis Pharma

    • Table Bicalutamide Product Benchmarking

    • Table Zeneca GmbH - Company Business Overview

    • Figure Zeneca GmbH Total Revenue from 2018 to 2020

    • Table Zeneca GmbH Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Zeneca GmbH Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Zeneca GmbH

    • Table Bicalutamide Product Benchmarking

    • Table Shanghai Zhaohui Pharmaceutical - Company Business Overview

    • Figure Shanghai Zhaohui Pharmaceutical Total Revenue from 2018 to 2020

    • Table Shanghai Zhaohui Pharmaceutical Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Shanghai Zhaohui Pharmaceutical Sales and Growth Rate Analysis of Bicalutamide

    • Figure Revenue and Market Share Analysis of Shanghai Zhaohui Pharmaceutical

    • Table Bicalutamide Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Bicalutamide Market Revenue by Types (Historical)

    • Table Global Bicalutamide Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Tablets 2016-2021

    • Figure Global Revenue and Growth Rate of Capsule 2016-2021

    • Table Global Bicalutamide Market Sales by Types (Historical)

    • Table Global Bicalutamide Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Tablets 2016-2021

    • Figure Global Sales and Growth Rate of Capsule 2016-2021

    • Table Global Bicalutamide Market Revenue by Types (Forecast)

    • Table Global Bicalutamide Market Revenue Market Share by Types (Forecast)

    • Table Global Bicalutamide Market Sales by Types (Forecast)

    • Table Global Bicalutamide Market Sales Market Share by Types (Forecast)

    • Figure Global Bicalutamide Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Bicalutamide

    • Table Global Bicalutamide Market Revenue by Application (Historical)

    • Table Global Bicalutamide Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Single Drug For Prostate Cancer 2016-2021

    • Figure Global Revenue and Growth Rate of Combined Chemotherapy For Prostate Cancer 2016-2021

    • Figure Global Revenue and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer 2016-2021

    • Table Global Bicalutamide Market Sales by Application (Historical)

    • Table Global Bicalutamide Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Single Drug For Prostate Cancer 2016-2021

    • Figure Global Sales and Growth Rate of Combined Chemotherapy For Prostate Cancer 2016-2021

    • Figure Global Sales and Growth Rate of Combined Radiation Therapy Or Castration For Prostate Cancer 2016-2021

    • Table Global Bicalutamide Market Revenue by Application (Forecast)

    • Table Global Bicalutamide Market Revenue Market Share by Application (Forecast)

    • Table Global Bicalutamide Market Sales by Application (Forecast)

    • Table Global Bicalutamide Market Sales Market Share by Application (Forecast)

    • Table Global Bicalutamide Market Revenue by Geography (Historical)

    • Table Global Bicalutamide Market Revenue Market Share by Geography (Historical)

    • Figure Global Bicalutamide Revenue Market Share by Geography in 2020

    • Table Global Bicalutamide Market Sales by Geography (Historical)

    • Table Global Bicalutamide Market Sales Market Share by Geography (Historical)

    • Figure Global Bicalutamide Sales Market Share by Geography in 2020

    • Table Global Bicalutamide Market Revenue by Geography (Forecast)

    • Table Global Bicalutamide Market Revenue Market Share by Geography (Forecast)

    • Table Global Bicalutamide Market Sales by Geography (Forecast)

    • Table Global Bicalutamide Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Bicalutamide Revenue by Countries from 2016 to 2026

    • Table North America Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table North America Bicalutamide Sales by Countries from 2016 to 2026

    • Table North America Bicalutamide Sales Market Share by Countries from 2016 to 2026

    • Figure North America Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure USA Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure USA Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table North America Bicalutamide Sales by Types from 2016 to 2026

    • Table North America Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table North America Bicalutamide Value by Types from 2016 to 2026

    • Table North America Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table North America Bicalutamide Sales by Application from 2016 to 2026

    • Table North America Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table North America Bicalutamide Value by Application from 2016 to 2026

    • Table North America Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table Europe Bicalutamide Revenue by Countries from 2016 to 2026

    • Table Europe Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table Europe Bicalutamide Sales by Countries from 2016 to 2026

    • Table Europe Bicalutamide Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure Germany Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure France Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure France Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Bicalutamide Sales by Types from 2016 to 2026

    • Table Europe Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table Europe Bicalutamide Value by Types from 2016 to 2026

    • Table Europe Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table Europe Bicalutamide Sales by Application from 2016 to 2026

    • Table Europe Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table Europe Bicalutamide Value by Application from 2016 to 2026

    • Table Europe Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table Asia Bicalutamide Revenue by Countries from 2016 to 2026

    • Table Asia Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table Asia Bicalutamide Sales by Countries from 2016 to 2026

    • Table Asia Bicalutamide Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure China Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure China Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure India Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure India Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Bicalutamide Sales by Types from 2016 to 2026

    • Table Asia Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table Asia Bicalutamide Value by Types from 2016 to 2026

    • Table Asia Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table Asia Bicalutamide Sales by Application from 2016 to 2026

    • Table Asia Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table Asia Bicalutamide Value by Application from 2016 to 2026

    • Table Asia Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table South America Bicalutamide Revenue by Countries from 2016 to 2026

    • Table South America Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table South America Bicalutamide Sales by Countries from 2016 to 2026

    • Table South America Bicalutamide Sales Market Share by Countries from 2016 to 2026

    • Figure South America Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure Brazil Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table South America Bicalutamide Sales by Types from 2016 to 2026

    • Table South America Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table South America Bicalutamide Value by Types from 2016 to 2026

    • Table South America Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table South America Bicalutamide Sales by Application from 2016 to 2026

    • Table South America Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table South America Bicalutamide Value by Application from 2016 to 2026

    • Table South America Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table Middle East Bicalutamide Revenue by Countries from 2016 to 2026

    • Table Middle East Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table Middle East Bicalutamide Sales by Countries from 2016 to 2026

    • Table Middle East Bicalutamide Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Bicalutamide Sales by Types from 2016 to 2026

    • Table Middle East Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table Middle East Bicalutamide Value by Types from 2016 to 2026

    • Table Middle East Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table Middle East Bicalutamide Sales by Application from 2016 to 2026

    • Table Middle East Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table Middle East Bicalutamide Value by Application from 2016 to 2026

    • Table Middle East Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table Africa Bicalutamide Revenue by Countries from 2016 to 2026

    • Table Africa Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table Africa Bicalutamide Sales by Countries from 2016 to 2026

    • Table Africa Bicalutamide Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure Nigeria Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Bicalutamide Sales by Types from 2016 to 2026

    • Table Africa Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table Africa Bicalutamide Value by Types from 2016 to 2026

    • Table Africa Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table Africa Bicalutamide Sales by Application from 2016 to 2026

    • Table Africa Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table Africa Bicalutamide Value by Application from 2016 to 2026

    • Table Africa Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table Oceania Bicalutamide Revenue by Countries from 2016 to 2026

    • Table Oceania Bicalutamide Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Bicalutamide Revenue Market Share by Major Countries in 2020

    • Table Oceania Bicalutamide Sales by Countries from 2016 to 2026

    • Table Oceania Bicalutamide Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Bicalutamide Sales Market Share by Major Countries in 2020

    • Figure Australia Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Value and Growth Rate from 2016 to 2026

    • Figure Others Bicalutamide Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Bicalutamide Sales by Types from 2016 to 2026

    • Table Oceania Bicalutamide Sales Market Share by Types from 2016 to 2026

    • Table Oceania Bicalutamide Value by Types from 2016 to 2026

    • Table Oceania Bicalutamide Value Market Share by Types from 2016 to 2026

    • Table Oceania Bicalutamide Sales by Application from 2016 to 2026

    • Table Oceania Bicalutamide Sales Market Share by Application from 2016 to 2026

    • Table Oceania Bicalutamide Value by Application from 2016 to 2026

    • Table Oceania Bicalutamide Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Bicalutamide

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Bicalutamide with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US